These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3049162)

  • 41. Effects of conversion of an invariant tryptophan residue to phenylalanine on the function of human dihydrofolate reductase.
    Huang SM; Delcamp TJ; Tan XH; Smith PL; Prendergast NJ; Freisheim JH
    Biochemistry; 1989 Jan; 28(2):471-8. PubMed ID: 2713326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of binding site of anti-tumour necrosis factor-alpha monoclonal antibody using hybrid and mutant proteins.
    Shingarova LN; Sagaidak LN; Berkova N; Korobko VG
    FEBS Lett; 1996 May; 386(1):72-4. PubMed ID: 8635607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics of murine chromosome 17 containing three tumor necrosis factor family genes, including the gene of the transmembrane subunit of lymphotoxin].
    Kuprash DV; Alimzhanov MB; Pokholok DK; Kozlov SV; Novobrantseva TI; Turetskaia RL; Nedospasov SA
    Dokl Akad Nauk; 1994 Aug; 337(5):683-6. PubMed ID: 7987231
    [No Abstract]   [Full Text] [Related]  

  • 44. The ligands and receptors of the lymphotoxin system.
    Ware CF; VanArsdale TL; Crowe PD; Browning JL
    Curr Top Microbiol Immunol; 1995; 198():175-218. PubMed ID: 7774281
    [No Abstract]   [Full Text] [Related]  

  • 45. Cloning and expression of human lymphotoxin mRNA derived from a human T cell hybridoma.
    Kobayashi Y; Miyamoto D; Asada M; Obinata M; Osawa T
    J Biochem; 1986 Sep; 100(3):727-33. PubMed ID: 3536896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of a partial synthetic human TNF cDNA in E. coli.
    Li CB; Chai CX; Xie Y; Lü Q; Chai JH; Yu H; Chen CM; Lin LZ; Wang QS; Li ZL
    Sci China B; 1992 Mar; 35(3):319-28. PubMed ID: 1590916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Site-directed mutagenesis of catalytic active-site residues of Taka-amylase A.
    Nagashima T; Tada S; Kitamoto K; Gomi K; Kumagai C; Toda H
    Biosci Biotechnol Biochem; 1992 Feb; 56(2):207-10. PubMed ID: 1377974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis.
    Van Ostade X; Tavernier J; Prangé T; Fiers W
    EMBO J; 1991 Apr; 10(4):827-36. PubMed ID: 2009860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Construction of a gene coding for the precursor of human tumor necrosis factor].
    Korobko VG; Selezneva II; Shingarova LN; Filippov SA; Dobrynin VN
    Bioorg Khim; 1991 Oct; 17(10):1365-8. PubMed ID: 1804120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational analysis of structure--activity relationships in human tumor necrosis factor-alpha.
    Yamagishi J; Kawashima H; Matsuo N; Ohue M; Yamayoshi M; Fukui T; Kotani H; Furuta R; Nakano K; Yamada M
    Protein Eng; 1990 Aug; 3(8):713-9. PubMed ID: 2217144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence by site-directed mutagenesis supports long-range electron transfer in mouse ribonucleotide reductase.
    Rova U; Goodtzova K; Ingemarson R; Behravan G; Gräslund A; Thelander L
    Biochemistry; 1995 Apr; 34(13):4267-75. PubMed ID: 7703240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of a membrane transport protein for fluorescence spectroscopy.
    Menezes ME; Roepe PD; Kaback HR
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1638-42. PubMed ID: 2408040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression.
    Force WR; Walter BN; Hession C; Tizard R; Kozak CA; Browning JL; Ware CF
    J Immunol; 1995 Dec; 155(11):5280-8. PubMed ID: 7594541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histidine-15: an important role in the cytotoxic activity of human tumor necrosis factor.
    Yamamoto R; Wang A; Vitt CR; Lin LS
    Protein Eng; 1989 May; 2(7):553-8. PubMed ID: 2546145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Preparation of lymphotoxin and properties of it].
    Lebedev LR; Pustoshilova NM; Sinichkina SA; Andreeva IS
    Prikl Biokhim Mikrobiol; 1998; 34(1):120-6. PubMed ID: 9566293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A lymphotoxin-beta-specific receptor.
    Crowe PD; VanArsdale TL; Walter BN; Ware CF; Hession C; Ehrenfels B; Browning JL; Din WS; Goodwin RG; Smith CA
    Science; 1994 Apr; 264(5159):707-10. PubMed ID: 8171323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor necrosis factors.
    Goetz FW; Planas JV; MacKenzie S
    Dev Comp Immunol; 2004 May; 28(5):487-97. PubMed ID: 15062645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contribution to activity of histidine-aromatic, amide-aromatic, and aromatic-aromatic interactions in the extended catalytic site of cysteine proteinases.
    Brömme D; Bonneau PR; Purisima E; Lachance P; Hajnik S; Thomas DY; Storer AC
    Biochemistry; 1996 Apr; 35(13):3970-9. PubMed ID: 8672429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular cloning of a Schizosaccharomyces pombe cDNA encoding lanosterol synthase and investigation of conserved tryptophan residues.
    Corey EJ; Matsuda SP; Baker CH; Ting AY; Cheng H
    Biochem Biophys Res Commun; 1996 Feb; 219(2):327-31. PubMed ID: 8604986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation.
    Kuprash DV; Osipovich OA; Pokholok DK; Alimzhanov MB; Biragyn A; Turetskaya RL; Nedospasov SA
    J Immunol; 1996 Apr; 156(7):2465-72. PubMed ID: 8786306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.